Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain

Toxicon

Volumn 54, Issue 5, 2009, Pages 647-653

  Abbott, Jason ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Botulinum toxin; Chronic pelvic pain; Pelvic floor myalgia; Provoked vestibulodynia

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; LAXATIVE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIGESTIVE SYSTEM DISEASE; DISEASE EXACERBATION; DYSCHESIA; DYSMENORRHEA; DYSPAREUNIA; FECES INCONTINENCE; FEMALE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; GENITAL PAIN; HUMAN; INFLAMMATION; INJECTION SITE BLEEDING; LONG TERM CARE; MUSCLE RESECTION; MUSCLE SPASM; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PHYSIOTHERAPY; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE; REPEATED DRUG DOSE; SYMPTOM; TREATMENT FAILURE; VAGINA PAIN; VAGINISM; VESTIBULODYNIA; VISUAL ANALOG SCALE; VULVODYNIA;

BOTULINUM TOXINS; CHRONIC DISEASE; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; NEUROMUSCULAR AGENTS; PELVIC FLOOR; PELVIC PAIN;

EID: 68849132402     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.01.036     Document Type: Article

References (37)

1. Abbott J. Botox for pelvic floor dysfunction. Toxicon 51 S1 (2008) 43
2. Abbott J., Jarvis S., Lyons S., Thomson A., and Vancaillie T. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomised controlled trial. Obstetrics and Gynecology 108 (2006) 915-923
3. Abbott J., Jarvis S., and Vancaillie T. Use of botulinum toxin for treatment of chronic pain and muscle spasm in the pelvic floor in women: outcomes at 5 years. Journal of Minimally Invasive Gynecology 14 (2007) S1
4. Bertolasi L., Bottanelli M., and Graziottin A. Dyspareunia, vaginismus, hyperactivity of the pelvic floor and botulin toxin: the neurologists role. Giornale Italiano di Ostetricia e Ginecologia 28 (2006) 264-268
5. Binder W., Brin M., Blitzer A., and Pogoda J. Botulinum toxin type A (BOTOX) for treatment of migraine. Seminars in Cutaneous Medicine and Surgery 20 (2001) 93-100
6. Brin M.F., and Vapnek J.M. Treatment of vaginismus with botulinum injections. Lancet 349 (1997) 252-253
7. Brown C.S., Glazer H.I., Vogt V., Menkes D., and Bachman G. Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia. Journal of Reproductive Medicine 51 (2006) 635-641
8. Brown S.R., Matabdul Y., and Shorthouse A.J. A second case of long-term incontinence following botulinum injection for anal fissure. Colorectal Disease 8 (2006) 452-453
9. Cheng C.M., Chen J.S., and Patel R.P. Unlabeled uses of botulinum toxins: a review, part 1. American Journal of Health-System Pharmacy 63 3 (2006) 225-232
10. Diener H.-C., Dowson A., Ferrari M., Nappi G., and Tfelt-Hansen P. Unbalanced randomization influences the placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalagia 19 (1999) 699-700
11. Dykstra D.D., and Presthus J. Botulinum toxin type A for the treatment of provoked vestibulodynia. Journal of Reproductive Medicine 51 (2006) 467-470
12. Edwards L. New concepts in vulvodynia. American Journal of Obstetrics and Gynecology 189 (2003) S24-S40
13. Floyd N.D., Kondylis L., Kondylis P.D., and Reilly J.C. Chronic anal fissure: 1994 and a decade later - are we doing better?. American Journal of Surgery 191 (2006) 344-348
14. Foster L., Clapp L., Erikson M., and Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 56 (2001) 1290-1293
15. Freeman E., and Rickels K. Characteristics of placebo responses in medical treatment of premenstrual syndrome. American Journal of Psychiatry 156 9 (1999) 1403-1408
16. Garrigues V., Galvez C., and Ortiz V. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population based survey in Spain. American Journal of Epidemiology 159 (2004) 520-526
17. Ghazizadeh S., and Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstetrics and Gynecology 104 (2004) 922-925
18. Gunter J., Brewer A., and Tawfik O. Botulinum toxin A for vulvodynia: a case report. Journal of Pain 5 (2004) 238-240
19. Howard F. The role of laparoscopy in the evaluation of chronic pelvic pain: pitfalls with a negative laparoscopy. Journal of the American Association of Gynecological Laparoscopists 4 (1996) 85-94
20. Hundley A., Wu J., and Visco A.G. A comparison of perineometer to Brink score for assessment of pelvic floor muscle strength. American Journal of Obstetrics and Gynecology 192 (2005) 1583-1591
21. Iswariah H., Stephens J., and Rieger N. Randomized prospective controlled trial of lateral internal sphincterotomy versus injections of botulinum toxin for the treatment of idiopathic fissure in ano. Australian and New Zealand Journal of Surgery 75 (2005) 553
22. Jarvis S., Abbott J., Lenart M., Steensma A., and Vancaillie T. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Australian and New Zealand Journal of Obstetrics and Gynaecology 44 (2004) 46-50
23. Jeffery S., Fynes M., Lee F., Wang K., Williams L., and Morley R. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU International 100 6 (2007) 1302-1306
24. Keshtgar A.S., Ward H.C., Sanei A., and Clayden G.S. Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: long-term follow-up of a double-blinded randomized trial. Journal of Pediatric Surgery 42 (2007) 672-680
25. Leippold T., Reitz A., and Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. European Urology 44 (2003) 165-174
26. Maria G., Cadeddu F., Brandara F., Marniga G., and Brisinda G. Experience with type A botulinum toxin for treatment of outlet-type constipation. American Journal of Gastroenterology 101 (2006) 2570-2575
27. Mathias S., Kupperman M., Liberman R., Lipschutz R., and Steege J. Chronic pelvic pain: prevalence, health related quality and economic correlates. Obstetrics and Gynecology 87 (1996) 321-327
28. Peng P.W., and Tumber P.S. Ultrasound-guided interventional procedures for patients with chronic pelvic pain - a description of techniques and review of literature. Pain Physician 11 (2008) 215-224
29. Romito S. Botulinum toxin for the treatment of genital pain syndromes. Gynecologic and Obstetric Investigation 58 (2004) 164-167
30. Shafik A., and El-Sibai O. Vaginismus: results of treatment with botulinum toxin. Journal of Obstetrics and Gynaecology 20 (2000) 300-302
31. Sinha D., Karri K., and Arunkalaivanan A.S. Applications of botulinum toxin in urogynaecology. European Journal of Obstetrics and Gynaecology and Reproductive Biology 133 (2007) 4-11
32. Thomson A., Jarvis S., Lenart M., Abbott J., and Vancaillie T. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. BJOG 112 (2005) 247-249
33. Truong D., Duane D., Jankovic J., Singer C., Seeberger L., Comella C., et al. Efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Movement Disorders 20 (2005) 783-791
34. Wall P. The placebo effect: an unpopular topic. Pain 51 (1992) 1-3
35. Westrom L.V., and Willen R. Vestibular nerve proliferation in vulvar vestibulitis syndrome. Obstetrics and Gynecology 91 (1998) 572-576
36. Wissel J., Muller J., Dressnandt J., Heinen F., Naumann M., Topeka H., et al. Management of spasticity associated pain with botulinum toxin type A. Journal of Pain Symptom Management 20 (2000) 44-49
37. Yoon H., Chung W., and Shim B. Botulinum toxin A for the management of vulvodynia. International Journal of Impotence Research 19 (2007) 84-87